azathioprine has been researched along with Nephrotic Syndrome in 201 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
Excerpt | Relevance | Reference |
---|---|---|
"Seven patients who had an initial attack of nephrotic syndrome in childhood and had frequent relapses even after cyclophosphamide therapy were given a 2-year course of azathioprine." | 9.09 | Efficacy of long-term azathioprine for relapsing nephrotic syndrome. ( Hiraoka, M; Hori, C; Mayumi, M; Momoi, T; Ohshima, Y; Seo, A; Tsukahara, H, 2000) |
"In a controlled double-blind trial five patients with the nephrotic syndrome due to idiopathic membranous glomerulonephritis received azathioprine, 2." | 9.04 | Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis. ( , 1976) |
"In a controlled trial, symptomatic treatment alone, or 12 weeks of cyclophosphamide or azathioprine were compared in Nigerian children with nephrotic syndrome (mainly quartan malarial nephropathy) and poorly selective proteinuria." | 9.04 | A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria. ( Adeniyi, A; Hendrickse, RG; Soothill, JF, 1979) |
"A controlled trial in 20 adult patients with the nephrotic syndrome due to proliferative glomerulonephritis compared the effects of consecutive eight-week courses of treatment with prednisolone in conventional dosage and a low-dose azathioprine-prednisolone combination." | 9.03 | Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine. ( Cameron, JS; Ogg, CS; Sharpstone, P, 1969) |
" This case report describes a patient with RA complicated by amyloidosis and the nephrotic syndrome, which regressed after treatment with azathioprine." | 8.79 | Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. ( Shapiro, DL; Spiera, H, 1995) |
"BACKGROUND Patients taking azathioprine (AZA) are very susceptible to development of cytomegalovirus (CMV) infection." | 8.02 | Cytomegalovirus-Associated Nephrotic Syndrome in a Patient with Myasthenia Gravis Treated with Azathioprine: A Case Report. ( Chen, M; Gu, X; Wang, Y; Xie, L; Xu, Y; Zhang, X, 2021) |
"Long-term azathioprine therapy as an alternative treatment to cyclophosphamide was done in 2 children with steroid-dependent minimal-change nephrotic syndrome (MCNS)." | 7.70 | Long-term azathioprine therapy in two children with steroid-dependent minimal-change nephrotic syndrome. ( Onodera, N; Tanaka, H; Waga, S, 1999) |
"Thirteen adult patients with nephrotic syndrome resistant to corticosteroid administration were treated with azathioprine daily for four years." | 7.67 | Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. ( Cade, R; Campbell, K; Croker, B; Mars, D; Peterson, J; Privette, M; Thompson, R, 1986) |
"A controlled trial of azathioprine treatment of steroid-responsive frequent-relapsing nephrotic syndrome of childhood failed to show a therapeutic effect on the stability of remission after withdrawal of corticosteroid treatment." | 7.65 | Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood. ( Barratt, TM; Cameron, JS; Chantler, C; Counahan, R; Ogg, CS; Soothill, JF, 1977) |
"Treatment with azathioprine in addition to colchicine could ameliorate the nephrotic syndrome and control the attacks very effectively in these cases." | 5.33 | Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases. ( Dogan, E; Erkoc, R; Sayarlioglu, H; Sayarlioglu, M; Soyoral, Y, 2006) |
"Nephrotic syndrome secondary to focal segmental glomerulosclerosis (FSGS) is a common cause of renal failure leading to transplantation." | 5.29 | Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients. ( Barcenas, C; Etheridge, WB; Jammal, C; Kahan, BD; Senel, MF; Van Buren, CT, 1996) |
"Seven patients who had an initial attack of nephrotic syndrome in childhood and had frequent relapses even after cyclophosphamide therapy were given a 2-year course of azathioprine." | 5.09 | Efficacy of long-term azathioprine for relapsing nephrotic syndrome. ( Hiraoka, M; Hori, C; Mayumi, M; Momoi, T; Ohshima, Y; Seo, A; Tsukahara, H, 2000) |
"Forty-seven SLE patients with severe renal disease characterized by renal biopsy documentation of diffuse proliferative or membranous glomerulonephritis or the nephrotic syndrome have been treated with azathioprine and prednisone in combination and followed for up to 12 years." | 5.04 | Longterm survival of lupus nephritis patients treated with azathioprine and prednisone. ( Barnett, EV; Dornfeld, L; Lee, DB; Liebling, MR, 1978) |
"In a controlled double-blind trial five patients with the nephrotic syndrome due to idiopathic membranous glomerulonephritis received azathioprine, 2." | 5.04 | Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis. ( , 1976) |
"A controlled trial in 20 adult patients with the nephrotic syndrome due to proliferative glomerulonephritis compared the effects of consecutive eight-week courses of treatment with prednisolone in conventional dosage and a low-dose azathioprine-prednisolone combination." | 5.03 | Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine. ( Cameron, JS; Ogg, CS; Sharpstone, P, 1969) |
"Randomised controlled trials (RCTs) and quasi-RCTs were included if they compared different immunosuppressive agents or non-immunosuppressive agents with placebo, prednisone or other agent given orally or parenterally in children aged three months to 18 years with steroid-resistant nephrotic syndrome (SRNS)." | 5.01 | Interventions for idiopathic steroid-resistant nephrotic syndrome in children. ( Craig, JC; Hodson, EM; Liu, ID; Willis, NS, 2019) |
" This case report describes a patient with RA complicated by amyloidosis and the nephrotic syndrome, which regressed after treatment with azathioprine." | 4.79 | Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. ( Shapiro, DL; Spiera, H, 1995) |
"BACKGROUND Patients taking azathioprine (AZA) are very susceptible to development of cytomegalovirus (CMV) infection." | 4.02 | Cytomegalovirus-Associated Nephrotic Syndrome in a Patient with Myasthenia Gravis Treated with Azathioprine: A Case Report. ( Chen, M; Gu, X; Wang, Y; Xie, L; Xu, Y; Zhang, X, 2021) |
" Forty of them, who presented a nephrotic syndrome, were treated by immunosuppressive drugs (prednisone, azathioprine, chlorambucil, cyclophosphamide) for 79 +/- 9." | 3.67 | Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis. ( Glyda, J; Gradowska, L; Juskowa, J; Klepacka, J; Lao, M; Morzycka-Michalik, M; Orlowski, T; Rancewicz, Z, 1988) |
"Thirteen adult patients with nephrotic syndrome resistant to corticosteroid administration were treated with azathioprine daily for four years." | 3.67 | Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. ( Cade, R; Campbell, K; Croker, B; Mars, D; Peterson, J; Privette, M; Thompson, R, 1986) |
"A controlled trial of azathioprine treatment of steroid-responsive frequent-relapsing nephrotic syndrome of childhood failed to show a therapeutic effect on the stability of remission after withdrawal of corticosteroid treatment." | 3.65 | Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood. ( Barratt, TM; Cameron, JS; Chantler, C; Counahan, R; Ogg, CS; Soothill, JF, 1977) |
" Amelioration of proteinuria and the plasma coagulation defect followed therapy with corticosteroids and azathioprine." | 3.65 | Factor IX deficiency in the nephrotic syndrome: studies with prothrombin complex concentrate. ( Natelson, EA; Rahman, F; Zanger, B, 1975) |
" The younger patient had the diagnosis confirmed at an early stage by renal biopsy, and under heparin and azathioprine the clinical signs, especially the nephrotic syndrome, regressed over a period of seven months." | 3.65 | [Amyloidosis in familial mediterranean fever: clinical and renal-biopsy features (author's transl)]. ( Angelkort, B; Brass, H; Buss, H; Heintz, R; Klein, H; Lapp, H, 1976) |
"A fall in proteinuria was recorded in both groups during treatment, but it rose significantly in Aza group (1." | 2.76 | Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study. ( Basta-Jovanovic, G; Jovanovic, D; Marinkovic, J; Naumovic, R; Pavlovic, S; Stosovic, M, 2011) |
"Primary membranous nephropathy (PMN) is a common cause of nephrotic syndrome in adults." | 2.72 | Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. ( Au, EH; Chen, Y; Hodson, EM; Mathew, AT; Tunnicliffe, DJ; von Groote, TC; Williams, G, 2021) |
" Prednisolone dosage was gradually tapered to 10 mg/d at 6 months, when cyclophosphamide was replaced by azathioprine (2 mg/kg/d p." | 2.69 | Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. ( Chan, KW; Chan, TM; Hao, WK; Lai, KN; Li, FK; Lui, SL; Tang, S, 1999) |
" Long-term follow-up trials focused on gonadal toxicity and limitation of maximum dosage of cyclophosphamide should been carried out." | 2.61 | Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials. ( Li, Q; Li, S; Tan, L; Wan, J; Yang, H; Zou, Q, 2019) |
" The renal tolerability of CsA is reasonably good when the dosage is low." | 2.43 | Treatment of focal segmental glomerulosclerosis. ( Meyrier, A, 2005) |
"The nephrotic syndrome is commonly caused by various glomerulonephritides, i." | 2.42 | [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy]. ( Takeda, Y; Tomino, Y, 2004) |
"Children with systemic lupus erythematosus and nephritis may benefit from the addition of cytotoxic agents to their corticosteroid regime, although the indications for this are not clear, and controlled evidence is lacking." | 2.36 | Immunosuppressive agents in the treatment of the nephrotic syndrome and glomerulonephritis in children. ( Cameron, JS, 1979) |
"Median proteinuria was 145,05 ± 85,54 mg/kg/24 hours." | 1.46 | [Idiopathic nephrotic syndrome (INS) in children in Dakar: about 40 cases]. ( Dial, CM; Diouf, B; Ka, EHF; Keita, Y; Lemrabott, AT; Moreira, C; Ndiaye, O; Ndongo, AA; Niang, A; Niang, B; Sall, MG; Sow, A; Sylla, A, 2017) |
"Treatment with prednisolone and azathioprine seems to be of no long-term benefit in ameliorating the clinical course of nephrotic patients with membranous nephropathy." | 1.33 | Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study. ( Ahuja, M; Brown, CB; Davlouros, P; El Nahas, AM; Goumenos, DS, 2006) |
"Treatment with azathioprine in addition to colchicine could ameliorate the nephrotic syndrome and control the attacks very effectively in these cases." | 1.33 | Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases. ( Dogan, E; Erkoc, R; Sayarlioglu, H; Sayarlioglu, M; Soyoral, Y, 2006) |
"Eighty nephrotic adults with focal segmental glomerulosclerosis (FSGS) and plasma creatinine lower than 3 mg/dL were given corticosteroids (53 patients) or immunosuppressive agents (27 patients) for a median of 16 and 75 weeks, respectively." | 1.30 | Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? ( Banfi, G; Baroli, A; Cesana, B; Farina, M; Grassi, C; Pani, A; Passerini, P; Ponticelli, C; Pozzi, C; Villa, M, 1999) |
"Nephrotic syndrome secondary to focal segmental glomerulosclerosis (FSGS) is a common cause of renal failure leading to transplantation." | 1.29 | Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients. ( Barcenas, C; Etheridge, WB; Jammal, C; Kahan, BD; Senel, MF; Van Buren, CT, 1996) |
"In rapid-progressing lupus nephritis and long active lupus nephritis with the phenomena of renal failure, the positive effect can only be attained after combination of steroid pulse therapy and high doses of prednisolone per os or long intake of cytostatics per os or in the form of cytostatic pulses." | 1.28 | [The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis]. ( Ianushkevich, TN; Klepikov, PV, 1990) |
"To evaluate the rate of recurrence of focal segmental glomerulosclerosis (FSGS) in renal transplant patients treated with cyclosporine, we reviewed the outcome of 25 renal Tx performed in 24 patients who had FSGS as their original renal disease." | 1.28 | The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. ( Banfi, G; Colturi, C; Montagnino, G; Ponticelli, C, 1990) |
" The corticosteroid dosage was proportional to each patient's weight." | 1.26 | Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome. ( Forman, AR; Loreto, JA; Tina, LU, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 153 (76.12) | 18.7374 |
1990's | 19 (9.45) | 18.2507 |
2000's | 13 (6.47) | 29.6817 |
2010's | 13 (6.47) | 24.3611 |
2020's | 3 (1.49) | 2.80 |
Authors | Studies |
---|---|
Xu, Y | 1 |
Chen, M | 1 |
Xie, L | 1 |
Zhang, X | 1 |
Wang, Y | 1 |
Gu, X | 1 |
von Groote, TC | 1 |
Williams, G | 1 |
Au, EH | 1 |
Chen, Y | 1 |
Mathew, AT | 1 |
Hodson, EM | 8 |
Tunnicliffe, DJ | 1 |
Liu, ID | 2 |
Willis, NS | 6 |
Craig, JC | 7 |
Larkins, NG | 1 |
Keita, Y | 1 |
Lemrabott, AT | 1 |
Sylla, A | 1 |
Niang, B | 1 |
Ka, EHF | 1 |
Dial, CM | 1 |
Ndongo, AA | 1 |
Sow, A | 1 |
Moreira, C | 1 |
Niang, A | 1 |
Ndiaye, O | 1 |
Diouf, B | 1 |
Sall, MG | 1 |
Olczak-Kowalczyk, D | 1 |
Roszkowska-Blaim, M | 1 |
Dąbkowska, M | 1 |
Swoboda-Kopeć, E | 1 |
Gozdowski, D | 1 |
Mizerska-Wasiak, M | 1 |
Demkow, U | 1 |
Pańczyk-Tomaszewska, M | 1 |
Tan, L | 1 |
Li, S | 1 |
Yang, H | 1 |
Zou, Q | 1 |
Wan, J | 1 |
Li, Q | 1 |
Pravitsitthikul, N | 1 |
Benck, U | 1 |
Banas, B | 1 |
Birck, R | 1 |
Hu, WX | 1 |
Chen, YH | 1 |
Bao, H | 1 |
Liu, ZZ | 1 |
Wang, SF | 1 |
Zhang, HT | 1 |
Liu, ZH | 1 |
Cabral, DA | 1 |
Canter, DL | 1 |
Muscal, E | 1 |
Nanda, K | 1 |
Wahezi, DM | 1 |
Spalding, SJ | 1 |
Twilt, M | 1 |
Benseler, SM | 1 |
Campillo, S | 1 |
Charuvanij, S | 1 |
Dancey, P | 1 |
Eberhard, BA | 1 |
Elder, ME | 1 |
Hersh, A | 1 |
Higgins, GC | 1 |
Huber, AM | 1 |
Khubchandani, R | 1 |
Kim, S | 1 |
Klein-Gitelman, M | 1 |
Kostik, MM | 1 |
Lawson, EF | 1 |
Lee, T | 1 |
Lubieniecka, JM | 1 |
McCurdy, D | 1 |
Moorthy, LN | 1 |
Morishita, KA | 1 |
Nielsen, SM | 1 |
O'Neil, KM | 1 |
Reiff, A | 1 |
Ristic, G | 1 |
Robinson, AB | 1 |
Sarmiento, A | 1 |
Shenoi, S | 1 |
Toth, MB | 1 |
Van Mater, HA | 1 |
Wagner-Weiner, L | 1 |
Weiss, JE | 1 |
White, AJ | 1 |
Yeung, RS | 1 |
Wong, SC | 1 |
Mitarai, T | 1 |
Naumovic, R | 1 |
Jovanovic, D | 1 |
Pavlovic, S | 1 |
Stosovic, M | 1 |
Marinkovic, J | 1 |
Basta-Jovanovic, G | 1 |
Habashy, D | 2 |
Hodson, E | 1 |
Craig, J | 1 |
Takeda, Y | 1 |
Tomino, Y | 1 |
Brockhurst, I | 1 |
Harris, KP | 1 |
Chapman, CS | 1 |
Meyrier, A | 1 |
Goumenos, DS | 1 |
Ahuja, M | 1 |
Davlouros, P | 1 |
El Nahas, AM | 1 |
Brown, CB | 1 |
Sayarlioglu, H | 1 |
Erkoc, R | 1 |
Sayarlioglu, M | 1 |
Dogan, E | 1 |
Soyoral, Y | 1 |
Kuhn, C | 1 |
Kuhn, A | 1 |
Markau, S | 1 |
Kästner, U | 1 |
Osten, B | 1 |
Hattori, M | 1 |
White, RH | 9 |
Adams, DA | 1 |
Gordon, A | 1 |
Maxwell, MH | 1 |
Rankin, LI | 1 |
Chopra, S | 1 |
Kaufman, JS | 1 |
Hamburger, RJ | 1 |
Flamenbaum, W | 1 |
Donadio, JV | 1 |
Kartasheva, VI | 1 |
Bosco Borghesan, A | 1 |
Cutaja, I | 1 |
Maringhini, S | 1 |
McCauley, J | 1 |
Shapiro, R | 1 |
Jordan, M | 1 |
Scantlebury, V | 1 |
Vivas, C | 1 |
Jensen, C | 1 |
Starzl, TE | 1 |
Senel, MF | 1 |
Van Buren, CT | 1 |
Etheridge, WB | 1 |
Barcenas, C | 1 |
Jammal, C | 1 |
Kahan, BD | 1 |
Kuriyama, R | 1 |
Kogure, H | 1 |
Itoh, S | 1 |
Kikuchi, K | 1 |
Ichikawa, N | 1 |
Nomura, Y | 1 |
Degawa, H | 1 |
Meigata, K | 1 |
Watanabe, K | 1 |
Beck, Y | 1 |
Tomikawa, S | 1 |
Nagao, T | 1 |
Uchida, H | 1 |
Shapiro, DL | 1 |
Spiera, H | 1 |
Konishi, T | 1 |
Miki, S | 1 |
Yoshida, A | 1 |
Tei, M | 1 |
Kullmann, F | 1 |
Kullmann, M | 1 |
Leser, HG | 1 |
Krämer, BK | 1 |
Riegger, AJ | 1 |
Schölmerich, J | 1 |
Schiel, R | 1 |
Bambauer, R | 1 |
Latza, R | 1 |
Klinkmann, J | 1 |
Janowski, R | 1 |
Majdan, M | 1 |
Mika, D | 1 |
Mierzicki, P | 1 |
Drop, A | 1 |
Ksiazek, A | 1 |
Baker, LR | 1 |
Tucker, B | 1 |
Macdougall, IC | 1 |
Oommen, R | 1 |
Klein, M | 1 |
Radhakrishnan, J | 1 |
Appel, G | 1 |
Pearson, ER | 1 |
D'Souza, RJ | 1 |
Hamilton-Wood, C | 1 |
Nicholls, AJ | 1 |
Beaman, M | 2 |
Tanaka, H | 1 |
Onodera, N | 1 |
Waga, S | 1 |
van den Berg, JS | 1 |
van Engelen, BG | 1 |
Boerman, RH | 1 |
de Baets, MH | 1 |
Chan, TM | 1 |
Li, FK | 1 |
Hao, WK | 1 |
Chan, KW | 1 |
Lui, SL | 1 |
Tang, S | 1 |
Lai, KN | 1 |
Ponticelli, C | 3 |
Villa, M | 1 |
Banfi, G | 2 |
Cesana, B | 1 |
Pozzi, C | 1 |
Pani, A | 1 |
Passerini, P | 2 |
Farina, M | 1 |
Grassi, C | 1 |
Baroli, A | 1 |
Hiraoka, M | 1 |
Tsukahara, H | 1 |
Hori, C | 1 |
Ohshima, Y | 1 |
Momoi, T | 1 |
Seo, A | 1 |
Mayumi, M | 1 |
Mastroianni Kirsztajn, G | 1 |
Nishida, SK | 1 |
Silva, MS | 1 |
Ajzen, H | 1 |
Pereira, AB | 1 |
Neverov, NI | 1 |
Stavrovskaia, EV | 1 |
Kolina, IB | 1 |
Shvetsov, MIu | 1 |
Zakharova, EV | 1 |
Shilov, EM | 1 |
Grupe, WE | 3 |
Morel-Maroger, L | 1 |
Méry, JP | 1 |
Droz, D | 1 |
Godin, M | 1 |
Verroust, P | 1 |
Kourilsky, O | 1 |
Richet, G | 1 |
Friedman, EA | 1 |
Ludwig, H | 1 |
Schernthaner, G | 1 |
Barnett, EV | 1 |
Dornfeld, L | 1 |
Lee, DB | 1 |
Liebling, MR | 1 |
Adeniyi, A | 3 |
Hendrickse, RG | 4 |
Soothill, JF | 3 |
Cameron, JS | 6 |
Tareeva, IE | 1 |
Semenkova, EN | 1 |
Filimonova, RG | 2 |
Ianushkevich, TN | 2 |
Singer, L | 2 |
Imbs, JL | 2 |
Singer, P | 1 |
Danion, JM | 2 |
Blanchard, WB | 1 |
Bucciarelli, RL | 1 |
Miller, BL | 1 |
Barratt, TM | 2 |
Chantler, C | 1 |
Counahan, R | 1 |
Ogg, CS | 4 |
Forman, AR | 1 |
Loreto, JA | 1 |
Tina, LU | 1 |
Rahman, F | 1 |
Zanger, B | 1 |
Natelson, EA | 1 |
Thiele, KG | 1 |
Trainin, EB | 1 |
Boichis, H | 1 |
Spitzer, A | 1 |
Edelmann, CM | 2 |
Greifer, I | 2 |
Harvey, TC | 1 |
Thomas, BJ | 1 |
James, H | 1 |
Chettle, DR | 1 |
Ettinger, KV | 1 |
Dykes, PW | 1 |
Jain, S | 1 |
Chen, NS | 1 |
Fremlin, JH | 1 |
Sergeeva, KM | 1 |
Grinbaum, NB | 1 |
Sakai, O | 1 |
Inoue, M | 1 |
Brass, H | 1 |
Klein, H | 1 |
Buss, H | 1 |
Lapp, H | 1 |
Heintz, R | 1 |
Angelkort, B | 1 |
Lindeman, RD | 2 |
Pederson, JA | 1 |
Matter, BJ | 1 |
Laughlin, LO | 1 |
Mandal, AK | 1 |
Sasinka, M | 1 |
Plenta, I | 1 |
Pavlovic, M | 1 |
Izakovic, V | 1 |
Kaiserová, E | 1 |
Páleníková, O | 1 |
Stubna, J | 1 |
Kuijten, RH | 1 |
Donckerwolcke, RA | 1 |
Tiddens, HA | 2 |
Welsch, M | 1 |
Klepikov, PV | 1 |
Colturi, C | 1 |
Montagnino, G | 1 |
Orlowski, T | 2 |
Rancewicz, Z | 1 |
Lao, M | 1 |
Juskowa, J | 1 |
Klepacka, J | 1 |
Gradowska, L | 1 |
Morzycka-Michalik, M | 1 |
Glyda, J | 2 |
Fujimoto, S | 1 |
Yamamoto, Y | 1 |
Wakisaka, O | 1 |
Hisanaga, S | 1 |
Miyata, J | 1 |
Tanaka, K | 1 |
Erbay, B | 1 |
Karatan, O | 1 |
Duman, N | 1 |
Ertuğ, AE | 1 |
Howie, AJ | 1 |
Hardwicke, J | 1 |
Michael, J | 1 |
Adu, D | 1 |
Cade, R | 1 |
Mars, D | 1 |
Privette, M | 1 |
Thompson, R | 1 |
Croker, B | 1 |
Peterson, J | 1 |
Campbell, K | 1 |
Belovezhdov, N | 1 |
Glasgow, EF | 6 |
Siegel, NJ | 1 |
Hayslett, JP | 3 |
Mukherjee, AP | 1 |
Diekmann, L | 1 |
Hüther, W | 1 |
Manitz, G | 1 |
Mönninghoff, W | 1 |
McIntosh, RM | 1 |
Griswold, W | 1 |
Smith, FG | 1 |
Kaufman, DB | 1 |
Urizar, R | 1 |
Vernier, RL | 2 |
Edington, GM | 1 |
Houba, V | 2 |
Waterhouse, C | 1 |
Abraham, G | 1 |
Vaughan, J | 1 |
McDonald, J | 1 |
Murphy, AV | 1 |
Arneil, GC | 6 |
Swanson, MA | 1 |
Schwartz, RS | 2 |
Harlan, WR | 1 |
Holden, KR | 1 |
Williams, GM | 1 |
Hume, DM | 1 |
Wojtulewicz-Kurkus, J | 1 |
Kunert, Z | 1 |
Abramowicz, M | 1 |
Barnett, HL | 1 |
Kobayashi, O | 1 |
Barron, BA | 1 |
Gordillo-P, G | 1 |
Hallman, N | 1 |
Mills, RJ | 2 |
Olbing, H | 1 |
Nieth, H | 1 |
Pachioli, R | 2 |
Genova, R | 3 |
Sarre, H | 2 |
Cagli, V | 1 |
Cicognani, A | 1 |
Mei, V | 1 |
Pirazzoli, P | 1 |
Tassoni, P | 1 |
Collina, A | 1 |
Tazzari, R | 1 |
Cacciari, E | 1 |
Karpouzas, J | 1 |
Psimenos, G | 1 |
Frimas, C | 1 |
Glassock, RJ | 1 |
McGinn, JT | 1 |
McGinn, TG | 1 |
Cherubin, CE | 1 |
Hoffman, RS | 1 |
Meadow, SR | 1 |
Moncrieff, MW | 1 |
Zech, P | 1 |
Richard, P | 1 |
Blanc-Brunat, N | 1 |
Labeeuw, M | 1 |
Colon, S | 1 |
Pozet, N | 1 |
Dupont, E | 1 |
Fries, D | 1 |
Traeger, J | 1 |
Barratt, M | 1 |
Skinner, MD | 1 |
Brodehl, J | 1 |
Wing, AJ | 1 |
Hutt, MS | 1 |
Kibukamusoke, JW | 2 |
Kallen, RJ | 1 |
Lewis, EJ | 1 |
Black, DA | 1 |
Wallnöfer, H | 1 |
Hanusch, M | 1 |
Rosman, M | 1 |
Bertino, JR | 1 |
Linshaw, MA | 1 |
Gruskin, AB | 1 |
Joppich, R | 1 |
Kampf, D | 1 |
Baethke, R | 1 |
Cheigh, JS | 1 |
Stenzel, KH | 1 |
Susin, M | 1 |
Rubin, AL | 1 |
Riggio, RR | 1 |
Whitsell, JC | 1 |
Wiltink, WF | 1 |
van Eijk, HG | 1 |
Bobeck-Rutsaert, MM | 1 |
Gerbrandy, J | 1 |
Leijnse, B | 1 |
Brys, R | 1 |
Ringoir, S | 1 |
Elewaut, A | 1 |
Barbier, F | 1 |
Alatas, H | 1 |
Wirja, IG | 1 |
Lyons, H | 1 |
Pinn, VW | 1 |
Cortell, S | 1 |
Cohen, JJ | 1 |
Harrington, JT | 1 |
Kashgarian, M | 1 |
Bensch, KG | 1 |
Spargo, BH | 1 |
Freedman, LR | 1 |
Epstein, FH | 1 |
Balslov, JT | 3 |
Brun, C | 3 |
Jensen, KB | 3 |
Jorgensen, F | 3 |
Jorgensen, HE | 3 |
Larsen, M | 2 |
Lorenzen, I | 3 |
Thomsen, AC | 2 |
Winkelstein, A | 1 |
Segel, D | 1 |
Stolzer, BL | 1 |
Fogel, M | 1 |
Shadduck, RK | 1 |
Lewis, M | 1 |
Rabkin, R | 1 |
Thatcher, GN | 1 |
Diamond, LH | 1 |
Eales, L | 1 |
Linneweh, F | 2 |
Ruilope, LM | 1 |
Casado, S | 1 |
López de Novales, E | 1 |
Barat, A | 1 |
Alvarez, J | 1 |
Hernando, L | 1 |
Hurley, RM | 2 |
Drummond, KN | 2 |
Makker, SP | 1 |
Heymann, W | 2 |
Keitel, W | 1 |
Kleine, FD | 1 |
Werner, R | 1 |
Spenney, JG | 1 |
Eure, CA | 1 |
Kreisberg, RA | 1 |
Sharpstone, P | 1 |
Urizar, RE | 1 |
Tinglof, B | 1 |
McIntosh, R | 1 |
Litman, N | 1 |
Barnett, E | 1 |
Wilkerson, J | 1 |
Smith, F | 1 |
Powell, KC | 1 |
Meadows, R | 1 |
Rossipal, E | 1 |
Bläker, F | 2 |
Holland, NH | 1 |
Bennett, NM | 1 |
Teehan, BP | 1 |
Argy, WP | 1 |
Schreiner, GE | 1 |
Alwall, N | 1 |
Halldorson, T | 1 |
Kjellstrand, CM | 1 |
Lindholm, T | 1 |
Ahlström, CG | 1 |
Varese, LA | 2 |
Yamashita, F | 1 |
Schnaars, P | 1 |
Spühler, O | 1 |
Zosin, C | 1 |
Mănescu, N | 1 |
Iacob, G | 1 |
Schwarzkopf, A | 1 |
Sabo, I | 1 |
Gluhovschi, G | 1 |
Miller, WE | 1 |
Vidt, DG | 1 |
Deodhar, SD | 1 |
Gifford, RW | 1 |
Humphrey, DC | 1 |
Boda, D | 1 |
Koltay, M | 1 |
Virág, I | 1 |
Terplan, M | 1 |
Lagrue, G | 2 |
Bariety, J | 2 |
Kaplan, NG | 1 |
Kaplan, KC | 1 |
Pachiolo, R | 1 |
Levitt, JI | 1 |
Dibelková, M | 1 |
Misarová, Z | 1 |
Holotová, J | 1 |
Pavkovceková, O | 1 |
Jurkovic, I | 1 |
Tischler, V | 1 |
Mydlík, M | 1 |
Sanjo, T | 2 |
Kurosawa, T | 2 |
Maeda, T | 2 |
McDonald, R | 1 |
Thomsen, A | 1 |
Tarejew, EM | 1 |
Muchin, NA | 1 |
Poljanzewa, LR | 1 |
Tarejewa, IE | 1 |
Kämpfen, P | 1 |
Hodler, J | 1 |
Gordillo, G | 1 |
García-Antillón, L | 1 |
Asamer, H | 1 |
Dittrich, M | 1 |
Mehls, O | 1 |
Schärer, K | 1 |
Halvorsen, S | 1 |
Lieberman, E | 1 |
Heuser, E | 1 |
Hanson, V | 1 |
Kornreich, H | 1 |
Donnell, GN | 1 |
Landing, BH | 1 |
Taglioretti, D | 1 |
Giangrande, A | 1 |
O'Dwyer, WF | 1 |
Oechslen, D | 1 |
Kluthe, R | 1 |
Schwalbová, M | 1 |
Krajci-Lazáryová, M | 1 |
Misíková, Z | 1 |
Szotowa, W | 1 |
Ludwiczak, H | 1 |
Oknińska, A | 1 |
Zeligowska, J | 1 |
Serejska, E | 1 |
Nowak, S | 1 |
Bodalski, J | 1 |
Margolis, A | 1 |
Michalak, A | 1 |
Bianchessi, M | 1 |
Porro, GB | 1 |
Tagliabue, M | 1 |
Butler, HE | 1 |
Morgan, JM | 1 |
Smythe, CM | 1 |
Trounce, JR | 1 |
Yoshida, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
an Open Parallel Clinical Trial in HBV-GN Patients[NCT01152060] | 10 participants (Anticipated) | Observational | 2010-01-31 | Active, not recruiting | |||
European Multicenter and Open-Label Controlled Randomized Trial to Evaluate the Efficacy of Sequential Treatment With Tacrolimus-Rituximab Versus Steroids Plus Cyclophosphamide in Patients With Primary Membranous Nephropathy (The STARMEN Study)[NCT01955187] | Phase 3 | 86 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
Mycophenolate Mofetil and Tacrolimus vs Tacrolimus Alone for the Treatment of Idiopathic Membranous Glomerulonephritis (IMG)[NCT00843856] | Phase 4 | 40 participants (Actual) | Interventional | 2009-03-03 | Completed | ||
A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Conventional Immunosuppressive Treatment on Proteinuria in Idiopathic Membranous Nephropathy (MN) and Focal Segmental Glomerulosclerosis (FSGS)[NCT00404833] | Phase 3 | 16 participants (Anticipated) | Interventional | 2003-01-31 | Completed | ||
A Dose-Finding Pilot Study of ACTH on the Serum Lipoprotein Profile and Proteinuria in Patients With Idiopathic Membranous Nephropathy (MN)[NCT00805753] | Phase 1 | 20 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
Treatment of Patients With Idiopathic Membranous Nephropathy at Risk for Renal Insufficiency: Comparison of Early Versus Late Start of Immunosuppressive Therapy[NCT00135954] | Phase 3 | 29 participants (Actual) | Interventional | 1997-07-31 | Completed | ||
A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Study of H.P. Acthar Gel (Acthar) in Treatment-Resistant Subjects With Persistent Proteinuria and Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy (iMN)[NCT01386554] | Phase 4 | 60 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy[NCT03018535] | Phase 3 | 76 participants (Actual) | Interventional | 2012-01-31 | Active, not recruiting | ||
Tacrolimus Treatment of Patients With Idiopathic[NCT00302523] | 16 participants (Actual) | Interventional | 2006-03-31 | Completed | |||
To Compare the Efficacy and Safety of TW vs Valsartan in the MN[NCT00518219] | Phase 4 | 68 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
A Dose-finding Pilot Study of ACTH (Adrenocorticotropic Hormone) on the Proteinuria and Serum Lipoprotein Profile in Patients With Idiopathic Membranous Nephropathy (MN)[NCT01093157] | Phase 1/Phase 2 | 10 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
Phase 3 Study of Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome[NCT00362531] | Phase 2/Phase 3 | 0 participants | Interventional | 2004-11-30 | Completed | ||
A Randomized Controlled Multi-center Trial of Mycophenolate Mofetil for the Patient With High Risk Membranous Nephropathy[NCT01282073] | Phase 3 | 62 participants (Anticipated) | Interventional | 2011-03-31 | Recruiting | ||
Opportunity, Validity and Security of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy : A Prospective, Randomized, Controlled, Multi-Center Clinical Trial[NCT02173106] | Phase 2 | 180 participants (Anticipated) | Interventional | 2014-06-30 | Recruiting | ||
Efficacy and Safety Evaluation of QingReMoShen Granule in the Treatment of Idiopathic Membranous Nephropathy : A Randomized Double-Blind Controlled Clinical Study[NCT01845688] | 72 participants (Actual) | Interventional | 2011-11-30 | Completed | |||
A Prospective Randomized, Controlled Trial of Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy[NCT03170323] | Phase 4 | 128 participants (Anticipated) | Interventional | 2018-07-01 | Recruiting | ||
Prospective Randomized Multicentric Open Label Study to Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy (IMN)[NCT01508468] | Phase 3 | 80 participants (Actual) | Interventional | 2012-01-17 | Completed | ||
"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"[NCT01180036] | Phase 2/Phase 3 | 130 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
BEL114674: A 2 Year Study of Efficacy and Safety of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy[NCT01762852] | Phase 2 | 0 participants (Actual) | Interventional | 2013-04-30 | Withdrawn (stopped due to Withdrawn due to difficulties in to recruiting due to competing studies, changing treatment practices, unavailability of eligible study population) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Efficacy of mycophenolate in preventing relapse of nephrotic syndrome secondary to membranous glomerulonephritis on withdrawal of tacrolimus therapy. (NCT00843856)
Timeframe: 10-109 weeks
Intervention | Participants (Count of Participants) |
---|---|
Tacrolimus | 8 |
Tacrolimus and Mycophenolate Mofetil | 8 |
The degree of remission of proteinuria obtained (complete or partial) The rate of decline of renal function measured by the Modification of Diet in Renal Disease equation for glomerular filtration rate. (NCT00843856)
Timeframe: 6-12 months
Intervention | Participants (Count of Participants) |
---|---|
Tacrolimus | 16 |
Tacrolimus and Mycophenolate Mofetil | 19 |
The participant's response was considered the average of the two PCR values from the 24-hour urine collections at Visit 8 (Week 24). (NCT01386554)
Timeframe: At Visit 9 (Week 28)
Intervention | Participants (Count of Participants) |
---|---|
Acthar 40U | 1 |
Acthar 80U | 4 |
Combined Placebo | 2 |
The participant's response was considered the average of the two PCR values from the 24-hour urine collected at Visit 8 (Week 24). Urine protein creatinine ratio (uPCR) was used to assess remission (partial and complete). Complete remission = uPCR < 0.3 g/g; partial remission = uPCR < 50% of baseline uPCR and > 0.3 g/g but < 3.0 g/g. (NCT01386554)
Timeframe: At Visit 8 (Week 24)
Intervention | Participants (Count of Participants) | |
---|---|---|
Partial remission in proteinuria | Complete remission in proteinuria | |
Acthar 40U | 1 | 0 |
Acthar 80U | 5 | 0 |
Combined Placebo | 2 | 0 |
The number of subjects to reach either complete remission or partial remission at 12 months after randomization. (NCT01180036)
Timeframe: 12 months after randomization
Intervention | Participants (Count of Participants) |
---|---|
Rituximab Treatment Arm | 39 |
Cyclosporine Treatment Arm | 34 |
The number of subjects to reach the composite of maintaining complete remission or partial remission at 24 months after randomization will be the primary endpoint. (NCT01180036)
Timeframe: 24 months after randomization
Intervention | Participants (Count of Participants) |
---|---|
Rituximab Treatment Arm | 39 |
Cyclosporine Treatment Arm | 13 |
32 reviews available for azathioprine and Nephrotic Syndrome
Article | Year |
---|---|
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cycloph | 2019 |
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Topics: Adolescent; Alkylating Agents; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide | 2020 |
Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Dru | 2019 |
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Hum | 2013 |
[Primary and secondary glomerular diseases].
Topics: Abatacept; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; Glomerul | 2014 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cycloph | 2016 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cycloph | 2010 |
[Immunosuppressive therapies for refractory nephrotic syndrome].
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Cytochrome P-4 | 2010 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agen | 2004 |
[Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Mycophenolic Acid; N | 2004 |
Treatment of focal segmental glomerulosclerosis.
Topics: Alkylating Agents; Antimetabolites; Azathioprine; Contraindications; Cyclophosphamide; Cyclosporine; | 2005 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cycloph | 2006 |
Non-corticosteroid treatment for nephrotic syndrome in children.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Hum | 2008 |
Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report.
Topics: Amyloidosis; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Middle Aged; | 1995 |
Cyclosporine treatment of glomerular diseases.
Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Drug Combinations; Glomerulonephritis; Glomerulonep | 1999 |
Primary nephrotic syndrome in childhood.
Topics: Azathioprine; Child; Chlorambucil; Cyclophosphamide; Edema; Hospitalization; Humans; Immunization; I | 1979 |
[The significance of immunologic mechanisms in the pathogenesis of renal diseases. 2. Immune complex nephritis, cell mediated reactions, pyelonephritis, therapeutic possibilities and conclusions].
Topics: Adrenal Cortex Hormones; Anticoagulants; Antigen-Antibody Complex; Azathioprine; Complement System P | 1978 |
Immunosuppressive agents in the treatment of the nephrotic syndrome and glomerulonephritis in children.
Topics: Azathioprine; Child; Chlorambucil; Cyclophosphamide; Glomerulonephritis; Humans; Immunosuppressive A | 1979 |
Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome.
Topics: Alkylating Agents; Azathioprine; Glomerulonephritis; Humans; Immunosuppressive Agents; Nephrosis, Li | 1991 |
Cytotoxic drugs in treatment of nonmalignant diseases.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlor | 1972 |
The nephrotic syndrome: current concepts.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Basement Membrane; Biopsy; Child; Cyclopho | 1972 |
Cytotoxic agents in childhood glomerulonephritis.
Topics: Adult; Agranulocytosis; Animals; Azathioprine; Child; Cyclophosphamide; Fertility; Glomerulonephriti | 1972 |
Immunosuppressive therapy. 2.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Chlorambucil; Clin | 1972 |
[Immunosuppressive therapy of the nephrotic syndrome in childhood].
Topics: Azathioprine; Child; Chlorambucil; Cyclophosphamide; Cystitis; Drug Resistance; Humans; Immunosuppre | 1972 |
"Immunosuppressive" treatment of "chronic glomerulonephritis".
Topics: Animals; Azathioprine; Child; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Female; F | 1973 |
Management of the nephrotic syndrome.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Clinical Trials as Topic; Cyclophos | 1974 |
[Nephrotic syndrome in childhood].
Topics: Adolescent; Age Factors; Azathioprine; Biopsy; Child; Child, Preschool; Chlorambucil; Cyclophosphami | 1974 |
[Therapy of glomerulonephritis with corticosteroids and immunosuppressive agents].
Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Azathioprine; Child; Cyclophosphamide; Diabetic Nephrop | 1974 |
[Pathophysiology of immunological processes. 3. Therapeutic influencing].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibody Formation; Antigen-Antibody Reactions; Arthritis, Rheu | 1968 |
The nephrotic syndrome.
Topics: Adolescent; Anti-Infective Agents; Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; | 1971 |
[Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome].
Topics: Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Deriv | 2010 |
19 trials available for azathioprine and Nephrotic Syndrome
Article | Year |
---|---|
Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans | 2011 |
Cyclosporine and therapeutic plasma exchange in treatment of progressive autoimmune diseases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibody Formation; Azathioprine; Behcet Syndrome; Combined Mo | 1997 |
Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
Topics: Adult; Alopecia; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Drug Ther | 1999 |
Efficacy of long-term azathioprine for relapsing nephrotic syndrome.
Topics: Adolescent; Adult; Age of Onset; Azathioprine; Child; Child, Preschool; Female; Follow-Up Studies; G | 2000 |
Urinary retinol-binding protein as a prognostic marker in the treatment of nephrotic syndrome.
Topics: Adolescent; Adult; Azathioprine; Biomarkers; Child; Creatinine; Cyclophosphamide; Cyclosporine; Fema | 2000 |
Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
Topics: Adolescent; Adult; Azathioprine; California; Clinical Trials as Topic; Drug Therapy, Combination; Fe | 1978 |
A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria.
Topics: Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Female; Follow-Up | 1979 |
Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis.
Topics: Adolescent; Adult; Aged; Azathioprine; Blood Urea Nitrogen; Clinical Trials as Topic; Female; Glomer | 1976 |
Immunosuppressive agents in childhood nephrotic syndrome.
Topics: Azathioprine; Child; Clinical Trials as Topic; Cyclophosphamide; Humans; Nephrotic Syndrome; Placebo | 1971 |
Selectivity of proteinuria and response to prednisolone or immunosuppressive drugs in children with malarial nephrosis.
Topics: Albuminuria; Azathioprine; Biopsy; Child; Complement System Proteins; Cyclophosphamide; Female; Fluo | 1970 |
Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.
Topics: Azathioprine; Biopsy; Child; Clinical Trials as Topic; Humans; Kidney Glomerulus; Nephrotic Syndrome | 1970 |
Immunosuppressive therapy. 2.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Chlorambucil; Clin | 1972 |
"Immunosuppressive" treatment of "chronic glomerulonephritis".
Topics: Animals; Azathioprine; Child; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Female; F | 1973 |
Therapeutic trials in renal disease.
Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Glomerulonephritis; Humans; Indomethacin; | 1972 |
[Treatment of chronic hepatitis with immunosuppressive agents and D-penicillamine].
Topics: Agranulocytosis; Azathioprine; Chronic Disease; Clinical Trials as Topic; Drug Hypersensitivity; Fem | 1973 |
Management of the nephrotic syndrome.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Clinical Trials as Topic; Cyclophos | 1974 |
Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine.
Topics: Adolescent; Adult; Aged; Azathioprine; Clinical Trials as Topic; Creatinine; Drug Synergism; Female; | 1969 |
An international cooperative study, societies of paediatric nephrology, and Henry L. Barnett.
Topics: Africa; Asia; Azathioprine; Central America; Child, Preschool; Clinical Trials as Topic; Europe; Fem | 1971 |
The nephrotic syndrome.
Topics: Adolescent; Anti-Infective Agents; Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; | 1971 |
154 other studies available for azathioprine and Nephrotic Syndrome
Article | Year |
---|---|
Cytomegalovirus-Associated Nephrotic Syndrome in a Patient with Myasthenia Gravis Treated with Azathioprine: A Case Report.
Topics: Azathioprine; Cytomegalovirus; Cytomegalovirus Infections; Humans; Myasthenia Gravis; Nephrotic Synd | 2021 |
[Idiopathic nephrotic syndrome (INS) in children in Dakar: about 40 cases].
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Female; Glucocorticoid | 2017 |
Enzymatic Activity of Candida spp. from Oral Cavity and Urine in Children with Nephrotic Syndrome.
Topics: Adolescent; Azathioprine; Bacteriuria; Candida; Candidiasis, Oral; Child; Child, Preschool; Cyclospo | 2017 |
Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Stud | 2015 |
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
Topics: Adolescent; Adrenal Cortex Hormones; Age Distribution; Antibodies, Antineutrophil Cytoplasmic; Asia; | 2016 |
Diagnosis and monitoring a case of light-chain deposition disease in the kidney using a new, sensitive immunoassay.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Basement Membrane; Disease Progression | 2005 |
Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Topics: Adult; Aged; Azathioprine; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomeru | 2006 |
Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases.
Topics: Adolescent; Adult; Amyloidosis; Antirheumatic Agents; Azathioprine; Colchicine; Drug Therapy, Combin | 2006 |
Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
Topics: Adult; Anemia, Megaloblastic; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2006 |
[Recent advances in therapy for nephrotic syndrome in children].
Topics: Anti-Inflammatory Agents; Azathioprine; Child; Chlorambucil; Cyclophosphamide; Drug Administration S | 2007 |
Cytotoxic drug therapy in steroid-resistant glomerulonephritis.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Azathioprine; Biopsy; Blood Protein Electrop | 1967 |
Azathioprine treatment of immunological renal disease.
Topics: Adolescent; Adult; Azathioprine; Chlorambucil; Cortisone; Female; Glomerulonephritis; Humans; Lupus | 1967 |
Nephrotic syndrome and pregnancy. Potential problems for mother and child.
Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Azathioprine; Cyclophosphamide; Female; Humans; Hy | 1984 |
Membranous nephropathy with chronic renal failure. Partial native renal function recovery after unsuccessful renal transplant.
Topics: Adult; Azathioprine; Creatinine; Graft Rejection; Humans; Kidney; Kidney Failure, Chronic; Kidney Tr | 1980 |
Primary glomerular disease: to treat or not to treat.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, | 1982 |
[Comparative effectiveness of different therapeutic regimens in lupus nephritis in children and adolescents].
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Evaluati | 1980 |
[Incidence in the past decade of nephrotic syndrome in childhood Therapeutic result of the use of 3 corticosteroids].
Topics: Age Factors; Azathioprine; Betamethasone; Child; Child, Preschool; Cyclophosphamide; Female; Humans; | 1980 |
FK 506 in the management of nephrotic syndrome after renal transplantation.
Topics: Azathioprine; Biopsy; Creatinine; Cyclosporine; Graft Rejection; Humans; Kidney Transplantation; Nep | 1993 |
Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Azathioprine; Cyclosporine; Glomerulosclerosis, | 1996 |
Angiotensin converting enzyme inhibitor induced anemia in a kidney transplant recipient.
Topics: Adult; Anemia; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Drug Therapy, Combination; En | 1996 |
[A post-thymomectomy case of myasthenia gravis which developed nephrotic syndrome with membranous nephropathy during azathioprine administration].
Topics: Azathioprine; Combined Modality Therapy; Female; Glomerulonephritis, Membranous; Glucocorticoids; Hu | 1996 |
[Nephrotic syndrome as the initial symptom of Crohn disease].
Topics: Amyloidosis; Azathioprine; Biopsy; Cecum; Combined Modality Therapy; Crohn Disease; Humans; Immunosu | 1996 |
[Pulmonary embolism as a complication of nephrotic syndrome--case report and therapeutic management].
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Cyclophosphamide; Drug Resistance; Drug Therapy, Combina | 1997 |
Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisolone.
Topics: Anti-Inflammatory Agents; Azathioprine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Ag | 1997 |
Hypertensive encephalopathy and nephrotic syndrome: a possible link?
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Azathioprine; Brain Diseases; Calcium Channel Blo | 1999 |
Long-term azathioprine therapy in two children with steroid-dependent minimal-change nephrotic syndrome.
Topics: Azathioprine; Child, Preschool; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Steroids | 1999 |
Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agen | 1999 |
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Dr | 1999 |
[Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antichole | 2001 |
The course of lupus nephritis: contribution of serial renal biopsies.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Child; Female; Glomerulonephritis; | 1976 |
Corticosteroids in immunosuppression: partial fulfillment of a promise.
Topics: Antibody Formation; Azathioprine; Cell Membrane; Cyclophosphamide; Glucocorticoids; Graft Rejection; | 1975 |
[Comparative evaluation of the effectiveness of corticosteroids and cytostatics in hypertensive variants of systemic nephritis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Azathioprine; Drug Evaluation; Dr | 1979 |
[Favorable course of a nephrotic syndrome despite the continuation of lithium therapy].
Topics: Animals; Azathioprine; Bipolar Disorder; Humans; Lithium; Male; Middle Aged; Nephrotic Syndrome; Rat | 1979 |
Ventricular parasystole in a newborn infant.
Topics: Adult; Arrhythmias, Cardiac; Azathioprine; Electrocardiography; Female; Follow-Up Studies; Glomerulo | 1979 |
Relapsing nephrotic syndrome in childhood.
Topics: Adolescent; Azathioprine; Cyclophosphamide; Humans; Male; Nephrotic Syndrome; Prednisone; Recurrence | 1979 |
The quartan malarial nephrotic syndrome.
Topics: Azathioprine; Capillaries; Child; Child, Preschool; Fluorescent Antibody Technique; Humans; Infant; | 1976 |
Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood.
Topics: Azathioprine; Child; Child, Preschool; Humans; Nephrotic Syndrome; Prednisolone; Recurrence | 1977 |
Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Cataract; Child; Child, Preschool; Cycloph | 1977 |
[Metabolism of peripheral blood lymphocytes in nephrotic syndrome and cytostatic therapy].
Topics: Acid Phosphatase; Adolescent; Adult; Azathioprine; Glycerophosphates; Humans; Lymphocytes; Middle Ag | 1976 |
Factor IX deficiency in the nephrotic syndrome: studies with prothrombin complex concentrate.
Topics: Azathioprine; Coagulants; Factor X; Female; Hemophilia B; Humans; Hypertension; Middle Aged; Nephrot | 1975 |
[Special pharmacotherapy of primary glomerulonephritis in the adult].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anticoagulants; Azathioprine; Cyclophosphamide; Dipyrid | 1975 |
Late nonresponsiveness to steroids in children with the nephrotic syndrome.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Drug Resistance; Female; Humans; Infant; Ma | 1975 |
Measurement of whole body nitrogen in living man by neutron activation analysis.
Topics: Activation Analysis; Adult; Arthritis, Rheumatoid; Azathioprine; Body Composition; Chlorpropamide; D | 1975 |
[Treatment of nephrotic syndrome of children with immunosuppressive agents (literature survey)].
Topics: Age Factors; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Evaluation; | 1975 |
[Management of steroid-resistant nephrotic syndrome in internal medicine].
Topics: Adult; Azathioprine; Drug Resistance; Female; Humans; Male; Nephrotic Syndrome; Prednisolone | 1975 |
[Amyloidosis in familial mediterranean fever: clinical and renal-biopsy features (author's transl)].
Topics: Acute Kidney Injury; Adolescent; Adult; Amyloidosis; Azathioprine; Biopsy; Familial Mediterranean Fe | 1976 |
Long-term azathioprine-corticosteroid therapy in lupus nephritis and idiopathic nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Drug Administration Schedule; Femal | 1976 |
[Complications of immunosuppresive therapy in chronic nephropathies in children].
Topics: Azathioprine; Child; Chronic Disease; Cyclophosphamide; Glomerulonephritis; Humans; Nephrotic Syndro | 1976 |
[Therapy of nephrotic syndrome in childhood].
Topics: Adolescent; Age Factors; Azathioprine; Biopsy; Child; Child, Preschool; Cyclophosphamide; Humans; In | 1976 |
[Nephrotic syndrome under lithium therapy].
Topics: Azathioprine; Humans; Kidney; Lithium; Male; Middle Aged; Nephrotic Syndrome; Prospective Studies | 1990 |
[The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Cyclophosp | 1990 |
The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine.
Topics: Adolescent; Adult; Age Factors; Azathioprine; Child; Child, Preschool; Cyclosporins; Female; Glomeru | 1990 |
Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
Topics: Adult; Azathioprine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up St | 1988 |
[Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Humans; Male; M | 1988 |
The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy.
Topics: Adrenal Cortex Hormones; Antibiotics, Antineoplastic; Azathioprine; Cyclosporins; Drug Evaluation; D | 1988 |
The glomerular tip lesion: a steroid responsive nephrotic syndrome.
Topics: Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Glomerulonephri | 1987 |
Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Creatinine; Drug Resistance; Female; | 1986 |
[Possibilities for treating patients with the idiopathic nephrotic syndrome].
Topics: Acenocoumarol; Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; | 1985 |
Membranoproliferative glomerulonephritis and persistent hypocomplementaemia.
Topics: Adolescent; Adult; Azathioprine; Beta-Globulins; Blood Protein Disorders; Child; Child, Preschool; C | 1970 |
Treatment of childhood nephrotic syndrome.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Humans; Nephrotic Syndrome; Prednisolone | 1971 |
Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults.
Topics: Adolescent; Adult; Azathioprine; Chlorambucil; Cholesterol; Creatinine; Cyclophosphamide; Female; Gl | 1971 |
[Clinical and morphological studies in nephrotic syndrome. Report on 83 children].
Topics: Azathioprine; Biopsy; Child; Child, Preschool; Cortisone; Cyclophosphamide; Female; Fluorescent Anti | 1972 |
Azathioprine in glomerulonephritis. A long-term study.
Topics: Adolescent; Azathioprine; Basement Membrane; Child; Chronic Disease; Follow-Up Studies; Glomerular F | 1972 |
Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children.
Topics: Antimalarials; Azathioprine; Basement Membrane; Biopsy; Capillaries; Child; Child, Preschool; Cyclop | 1972 |
The relationship between L-chain synthesis and gamma-globulin production.
Topics: Adult; Aged; Antibody Formation; Azathioprine; Female; gamma-Globulins; Humans; Immunoglobulin Fragm | 1973 |
Long-term assessment of cyclophosphamide therapy for nephrosis in children.
Topics: Adolescent; Age Factors; Alopecia; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cystitis | 1974 |
Immunosuppressive therapy. The relation between clinical response and immunologic competence.
Topics: Adolescent; Adult; Anemia, Hemolytic, Autoimmune; Antibody Formation; Azathioprine; Chronic Disease; | 1967 |
Proteinuria and nephrotic syndrome associated with chronic rejection of kidney transplants.
Topics: Azathioprine; Dactinomycin; Glomerulonephritis; Humans; Kidney Transplantation; Nephrotic Syndrome; | 1967 |
Immunosuppressive treatment of nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Amyloidosis; Azathioprine; Biopsy; Blood Proteins; Chlorambucil; Dactinomyc | 1969 |
Clinicopathological study of nephrotic syndrome in childhood.
Topics: Adolescent; Age Factors; Azathioprine; Beta-Globulins; Biopsy; Child; Child, Preschool; Cyclophospha | 1970 |
[Hazard-adapted therapy of acquired idiopathic nephrotic syndromes in children].
Topics: Adrenal Cortex Hormones; Azathioprine; Child; Cyclophosphamide; Female; Glomerulonephritis; Humans; | 1973 |
[Therapy of the nephrotic syndrome].
Topics: Adrenocorticotropic Hormone; Azathioprine; Chlorambucil; Chlorthalidone; Diet, Sodium-Restricted; Di | 1968 |
Treatment of the nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Azathioprine; Ch | 1970 |
Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
Topics: Adrenocorticotropic Hormone; Azathioprine; Child; Chronic Disease; Cyclophosphamide; Glomerulonephri | 1971 |
[Membraneous-proliferating glomerulonephritis associated with the nephrotic syndrome].
Topics: Adrenocorticotropic Hormone; Azathioprine; Contraception; Cyclophosphamide; Diet Therapy; Dietary Pr | 1971 |
[Therapy of nephrotic syndrome].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Cyclophosphamide; Diet Therapy; | 1971 |
[Body height increase and secretion of somatotropin in children with variously treated hephrotic syndromes].
Topics: Adrenocorticotropic Hormone; Azathioprine; Body Height; Child; Child, Preschool; Chronic Disease; Fe | 1973 |
Hereditary nephritis associated with nephrotic syndrome.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Humans; Kidney; | 1974 |
Cytotoxic drugs in primary glomerular disease.
Topics: Azathioprine; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Glomerulonephritis; Huma | 1974 |
Nephrotic syndrome in drug addicts.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Male; Nephrotic Syndrome; Prednisone; Prognos | 1974 |
Focal glomerulosclerosis in childhood.
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Atrophy; Azathioprine; Basement Membrane; Biopsy; | 1973 |
Mesangial proliferative glomerulonephritis in childhood.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Child, Preschool; Female; Follow-Up Studie | 1973 |
Schönlein-Henoch nephritis.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Biopsy; Child; Child, Preschool; Cyclophosphamide | 1972 |
[Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antimalarials; Azathioprine; Biopsy; Chlorambucil; | 1972 |
Progression and remission in the nehprotic syndrome associated with quartan malaria in Uganda.
Topics: Adolescent; Adult; Azathioprine; Biopsy; Blood Protein Electrophoresis; Child; Fluorescent Antibody | 1972 |
Kidney diseases in children. Forward.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Foundations; History, 15th Century; History | 1973 |
Azathioprine.
Topics: Arthritis, Rheumatoid; Asthma; Autoimmune Diseases; Azathioprine; Colitis, Ulcerative; Glomeruloneph | 1973 |
Kidney transplant nephrotic syndrome.
Topics: Adolescent; Adult; Animals; Azathioprine; Cadaver; Child; Female; Glomerulonephritis; Graft Rejectio | 1974 |
Urinary iron excretion in nephrotic syndrome.
Topics: Adult; Azathioprine; Female; Glomerulonephritis; Hemoglobinometry; Humans; Immunodiffusion; Iron; Ma | 1972 |
[Amyloidosis in Crohn's disease].
Topics: Amyloidosis; Azathioprine; Crohn Disease; Humans; Male; Nephrotic Syndrome | 1972 |
Treatment of childhood nephrotic syndrome with Imuran.
Topics: Administration, Oral; Azathioprine; Drug Therapy, Combination; Female; Humans; Male; Nephrotic Syndr | 1972 |
Allergic interstitial nephritis causing reversible renal failure in four patients with idiopathic nephrotic syndrome.
Topics: Acute Kidney Injury; Adult; Azathioprine; Chlorothiazide; Drug Hypersensitivity; Eosinophils; Female | 1973 |
Clinicopathological correlations in the nephrotic syndrome due to primary renal disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Autopsy; Azathioprine; Biopsy; Child; Child, Preschool; Chro | 1973 |
Cytostatic treatment of glomerular diseases. I. Effect of azathioprine on serum creatinine and proteinuria. Report from a Copenhagen Study Group of Renal Diseases.
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Child, Preschool; Creatinine; Female; Glo | 1973 |
Cytostatic treatment of glomerular diseases. II. Effect of azathioprine on serum and urine proteins. Report from a Copenhagen Study Group of Renal Diseases.
Topics: Adolescent; Adult; Aged; Albuminuria; Azathioprine; Blood Proteins; Child; Child, Preschool; Female; | 1973 |
Immunosuppressive therapy.
Topics: Anemia, Hemolytic, Autoimmune; Antigen-Antibody Reactions; Arthritis, Rheumatoid; Azathioprine; Croh | 1973 |
The nephrotic syndrome, malignancy and immunosuppression.
Topics: Azathioprine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nephrotic Syndrome | 1973 |
[Therapy of the nephrotic syndrome in children].
Topics: Adrenal Cortex Hormones; Azathioprine; Child; Child, Preschool; Humans; Immunosuppressive Agents; Ne | 1973 |
[Childhood nephrotic syndrome with minimun glomerular lesions (clinical development and therapeutic response in 40 cases)].
Topics: Adolescent; Azathioprine; Biopsy; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Female; H | 1973 |
Glomerular enlargement in primary renal disease: a quantitative study.
Topics: Adolescent; Adult; Age Factors; Aging; Autopsy; Azathioprine; Biopsy; Child; Child, Preschool; Cyclo | 1974 |
The idiopathic nephrotic syndrome of childhood. A clinical reevaluation of 148 cases.
Topics: Adolescent; Antistreptolysin; Azathioprine; Bacteriuria; Blood Urea Nitrogen; Child; Child, Preschoo | 1974 |
Management of the nephrotic syndrome.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Child, Preschool; Chlorothiazide; Diet Therapy; Diuretic | 1968 |
Hyperglycemic, hyperosmolar, nonketoacidotic diabetes. A complication of steroid and immunosupressive therapy.
Topics: Adult; Azathioprine; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetic Coma; Diagno | 1969 |
Immunosuppressive therapy of proliferative glomerulonephritis in children.
Topics: Adolescent; Autoantibodies; Azathioprine; Child; Complement System Proteins; Creatinine; Female; Flu | 1969 |
The nephrotic syndrome in new guinea--a clinical and histological spectrum.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Female; Glomerulonephritis; Humans; Kidney | 1971 |
[Prognosis of the idiopathic nephrotic syndrome in childhood by means of plasma protein clearance].
Topics: Age Factors; Azathioprine; Blood Proteins; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; | 1969 |
[Long term therapy of nephrotic syndrome and chronic glomerulonephritis in childhood].
Topics: Autoantibodies; Autoimmune Diseases; Azathioprine; Basement Membrane; Binding Sites; Child; Chronic | 1970 |
[Comparative estimation of the corticoid and immunosuppressive therapy in nephrotic syndrome].
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Humans; Nephrotic Syndrome | 1972 |
Hypocomplementemic (membranoproliferative) glomerulonephritis. Immunosuppressive therapy.
Topics: Adolescent; Adult; Azathioprine; Biopsy; Blood Urea Nitrogen; Child; Complement System Proteins; Cre | 1972 |
[Recommendations for immunosuppressive therapy of childhood glomerular kidney diseases].
Topics: Antibiotics, Antineoplastic; Azathioprine; Child; Cyclophosphamide; Humans; Immunosuppressive Agents | 1972 |
Steroid-resistant idiopathic nephrotic syndrome. Results of azathioprine treatment in adults.
Topics: Adolescent; Adult; Azathioprine; Female; Glomerulonephritis; Humans; Kidney Diseases; Lupus Erythema | 1972 |
On corticosteroid and azathioprine treatment of glomerular renal diseases. A study of 90 cases, treated 1964-1969.
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Collagen Diseases; Female; Glomerulonephritis; | 1972 |
Anaphylactoid purpura nephritis: clinicopathological correlations.
Topics: Adolescent; Azathioprine; Biopsy; Child; Child, Preschool; Female; Fibrin; Glomerulonephritis; Human | 1972 |
Corticosteroid and immunosuppressive therapy of idiopathic nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Microscop | 1971 |
Focal glomerulosclerosis--a progressive lesion associated with steroid-resistant nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Female | 1971 |
[On immunosuppressive therapy of primary nephrotic syndrome in the pediatric age].
Topics: Azathioprine; Child; Child, Preschool; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; | 1971 |
[Immunosuppressive therapy of nephrotic syndrome].
Topics: Azathioprine; Child; Cyclophosphamide; Humans; Immunosuppressive Agents; Nephrotic Syndrome | 1971 |
[Long-time treatment of chronic glomerulonephritis with azathioprine].
Topics: Azathioprine; Biopsy; Chronic Disease; Glomerulonephritis; Humans; Metabolic Clearance Rate; Nephrot | 1966 |
[Immunodepressive therapy in nephropathies].
Topics: Azathioprine; Chlorambucil; Collagen Diseases; Diabetic Nephropathies; Glomerulonephritis; Humans; I | 1969 |
Selectivity index as a guide to treatment in heavy proteinuria.
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Female; Humans; Immunosuppressive Agents; Kidn | 1969 |
[Immunosuppressive treatment of corticoid resistant nephrotic syndrome in childhood].
Topics: Azathioprine; Child; Child, Preschool; Chlorambucil; Dexamethasone; Female; Humans; Male; Nephrosis, | 1969 |
Prednisone-azathioprine therapy in primary renal disease.
Topics: Azathioprine; Female; Humans; Kidney Diseases; Nephrotic Syndrome; Prednisone | 1970 |
[Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
Topics: Adrenal Cortex Hormones; Alkylating Agents; Azathioprine; Chlorambucil; Glomerulonephritis; Humans; | 1970 |
Monoclonal gammopathy, glomerulonephritis and the nephrotic syndrome.
Topics: Azathioprine; Biopsy; Blood Proteins; Cholesterol; Creatinine; Glomerulonephritis; Humans; Immunoele | 1970 |
Results of immunodepressive treatment in the nephrotic syndrome.
Topics: Alopecia; Azathioprine; Child, Preschool; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressi | 1970 |
Deterioration of renal function after discontinuation of long-term prednisone-azathioprine therapy in primary renal disease.
Topics: Adult; Azathioprine; Drug Tolerance; Female; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Ki | 1970 |
[Experience with immunosuppressive therapy in 13 children with kidney diseases].
Topics: Azathioprine; Child; Chronic Disease; Cyclophosphamide; Glomerulonephritis; Humans; Immunosuppressiv | 1970 |
[Systemic lupus erythematosus and glomerulonephritis treated with Imuran (azathioprine) in 2 children].
Topics: Adolescent; Azathioprine; Child; Female; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; | 1970 |
[Nephrotic syndrome].
Topics: Adult; Azathioprine; Child; Female; Humans; Male; Middle Aged; Nephrotic Syndrome | 1970 |
[Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents)].
Topics: Antineoplastic Agents; Azathioprine; Chlorambucil; Glomerulonephritis; Humans; Immunosuppressive Age | 1970 |
Management of the nephrotic syndrome in children.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Diuretics; Edema; Female; Humans; Infant; M | 1970 |
[Treatment of kidney glomerular diseases with cytostatics].
Topics: Azathioprine; Creatinine; Glomerulonephritis; Humans; Nephrotic Syndrome; Proteinuria | 1970 |
[Cytostatics in the treatment of nephritides].
Topics: Adult; Antineoplastic Agents; Azathioprine; Dyspepsia; Female; Humans; Male; Mercaptopurine; Middle | 1970 |
[Treatment of chronic glomerulonephritis with imuran].
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Blood Sedimentation; Child; Chronic Disease; Colic; D | 1970 |
[Nephrotic syndrome in children. Report of an international cooperative study].
Topics: Azathioprine; Child; Child, Preschool; Humans; Infant; International Cooperation; Nephrotic Syndrome | 1970 |
QImmunosuppressive therapy of glomerulonephritis.
Topics: Azathioprine; Biopsy; Glomerulonephritis; Humans; Immunosuppressive Agents; Methotrexate; Nephrosis, | 1970 |
[Familial nephrotic syndrome].
Topics: Acute Kidney Injury; Adolescent; Adrenal Cortex Hormones; Age Factors; Azathioprine; Biopsy; Child; | 1970 |
[Treatment with immunosuppressive drugs in primary nephrotic syndromes in the pediatric age. Clinical studies].
Topics: Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Kidney Dise | 1971 |
[Cytostatic agents in treatment of the nephrotic syndrome].
Topics: Adult; Azathioprine; Child; Cyclophosphamide; Humans; Nephrotic Syndrome | 1971 |
Identical 3-year-old twins with disseminated lupus erythematosus: one with nephrosis and one with nephritis.
Topics: Azathioprine; Biopsy; Child, Preschool; Chloroquine; Diseases in Twins; Female; Humans; Kidney; Late | 1968 |
Azathioprine in myeloproliferative and autoimmune disorders.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Azathioprine; Colitis, | 1968 |
Malaria prophylaxis and immunosuppressant therapy in management of nephrotic syndrome associated with quartan malaria.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Female; Glomerulonephritis; Humans; Kidney Glomer | 1968 |
Persistent proteinuria.
Topics: Adolescent; Adult; Azathioprine; Female; Humans; Male; Nephrotic Syndrome; Proteinuria | 1968 |
[Cytostatic treatment of the steroid-resistant nephrotic syndrome. (Long term study on 24 patients)].
Topics: Adult; Azathioprine; Biopsy; Chlorambucil; Female; Glomerulonephritis; Humans; Kidney Function Tests | 1968 |
[Effect of immunosuppressive drugs on nephrotic syndrome].
Topics: Adult; Animals; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Pr | 1968 |
Management of the nephrotic syndrome in adult patients.
Topics: Adolescent; Adult; Azathioprine; Diuretics; Female; Glucocorticoids; Humans; Male; Middle Aged; Neph | 1969 |
[Immunosuppresive agents in the treatment of nephropathies of children].
Topics: Azathioprine; Child; Chlorambucil; Cyclophosphamide; Humans; Immunosuppressive Agents; Kidney Diseas | 1969 |
[Use of immunosuppressive cytostatic agents in children's diseases in our experience].
Topics: Adolescent; Autoimmune Diseases; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Collage | 1969 |
[Therapy of the nephrotic syndrome in childhood].
Topics: Azathioprine; Biopsy; Blood Proteins; Humans; Kidney; Nephrotic Syndrome; Prednisolone | 1969 |
[Attempts of the use of cytostatic agents in some forms of glomerulonephritis in children].
Topics: Adolescent; Antineoplastic Agents; Azathioprine; Child; Child, Preschool; Chlorambucil; Chronic Dise | 1969 |
Azathioprine for the nephrotic syndrome.
Topics: Adolescent; Adult; Azathioprine; Humans; Middle Aged; Nephrotic Syndrome; Proteinuria | 1969 |
Mercaptopurine and acquired tubular dysfunction in adult nephrosis.
Topics: Acidosis; Adult; Anemia; Azathioprine; Glomerulonephritis; Glycosuria; Humans; Leukopenia; Male; Nep | 1965 |
Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Biopsy; Child; Child, Preschool; Cyc | 1966 |
Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosp | 1966 |